4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-445438
Director acquired 1,428,571 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. Director | 2026-10-30 | Grant or award | +238,095 | $21.00 | $4,999,995 | 6,518,620 | D |
| Third Rock Ventures V, L.P. Director | 2026-10-30 | Grant or award | +1,190,476 | $21.00 | $24,999,996 | 2,159,694 | I |
Loading xslF345X06/ownership.xml…